Business Card for Thomas Stauffer:


Key Account Manager
 Hartford, CT area


1 Health Plz
East Hanover, NJ 07936
Tel: (862) 778-8300

Last updated on 2017-07-14

About Thomas Stauffer:

Thomas Stauffer works as an Key Account Manager for Novartis Corporation at Hartford, CT. The company's webpage is http://www.novartis.com. For email, phone number and executive profiles for Key Account Manager and other executives of Novartis Corporation at Hartford, CT, check Novartis Corporation at Joesdata.com. Not the Thomas Stauffer you are looking for? Do a quick search in our website and find other people named Thomas Stauffer.
Thomas Stauffer's Work History:
No information available..

Thomas Stauffer's Education:
No information available..

Thomas Stauffer's Co-workers:
As of February 26, 2021, Thomas Stauffer has 472 co-workers under the company name Novartis Corporation at Joesdata.com.

About Novartis Corporation:

Novartis Corporation is located at 1 Health Plz , East Hanover, NJ 07936. It has around 5K - 10K employees. Its revenue is around $500M - 1B.

Company News:
2017-08-21 21:19:37
Novartis launches first large-scale research study in multiple sclerosis that allows participants to contribute from smartphones
2017-07-12 21:37:03
Novartis CAR-T cell therapy CTL019 unanimously (10-0) recommended for approval by FDA advisory committee to treat pediatric, young adult r/r B-cell ALL
2017-06-23 21:36:37
Novartis pivotal CTL019 6-month follow-up data show durable remission rates in children, young adults with r/r B-cell ALL
2017-06-07 21:36:48
Novartis interim results from global, pivotal CTL019 trial show durable complete responses in adults with r/r DLBCL
2017-06-05 21:36:54
Novartis announces clinical collaboration with Bristol-Myers Squibb to evaluate potential treatments in metastatic colorectal cancer
2017-04-24 20:42:47
Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 (erenumab) program in migraine prevention in the U.S. and Canada
2017-04-19 20:48:34
NIH study in NEJM shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in severe aplastic anemia
2017-03-29 21:36:35
Novartis announces first CAR-T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted FDA Priority Review
2017-03-18 21:36:46
New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes
2016-12-21 21:41:51
Novartis out-licenses three COPD products in the US

People in the same industry: